FDA Inspection 1260763 — Courtney A. Schreiber, M.D.
The FDA completed an inspection of Courtney A. Schreiber, M.D. on Jan 31, 2025 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 31, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional Details
Sponsor-Investigator (S-I)